Key Points
-
A range of alternative techniques to wire-guided localization are available for localization of neoplastic lesions prior to surgical management of nonpalpable breast cancer
-
The use of radioguided localization is supported by data from meta-analyses; however, overall utilization of this technique has been poor owing to the logistical and legislative issues associated with radioisotope use
-
More than 95% of localization procedures include ultrasonography, making intraoperative ultrasonography a logical alternative, but this method requires evidence from randomized controlled trials and implementation of training programmes for surgeons
-
Techniques that use the principles of radioguided localization, but that are radioisotope free, could form the basis of future therapeutic options and warrant investigation in adequately powered clinical trials
-
Non-invasive surgery using high-intensity focused ultrasound is in its infancy, but could potentially enable real-time visualization and therapy of lesions as an outpatient procedure
Abstract
Breast cancer is the most-common cancer among women worldwide, and over one-third of all cases diagnosed annually are nonpalpable at diagnosis. The increasingly widespread implementation of breast-screening programmes, combined with the use of advanced imaging modalities, such as magnetic resonance imaging (MRI), will further increase the numbers of patients diagnosed with this disease. The current standard management for nonpalpable breast cancer is localized surgical excision combined with axillary staging, using sentinel-lymph-node biopsy in the clinically and radiologically normal axilla. Wire-guided localization (WGL) during mammography is a method that was developed over 40 years ago to enable lesion localization preoperatively; this technique became the standard of care in the absence of a better alternative. Over the past 20 years, however, other technologies have been developed as alternatives to WGL in order to overcome the technical and outcome-related limitations of this technique. This Review discusses the techniques available for the surgical management of nonpalpable breast cancer; we describe their advantages and disadvantages, and highlight future directions for the development of new technologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
ISD Scotland. Cancer Incidence in Scotland (2011) [online], (2013).
Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales. Cancer in Wales [online], (2015).
Office for National Statistics. Cancer Statistics Registrations, England (Series MB1), No. 44, 2013 [online], (2015).
Northern Ireland Cancer Registry. Breast [online], (2015).
Westlake, S. & Cooper, N. Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993 to 2004. Health Stat. Q. 2008, 33–46 (2008).
Health and Social Care Information Centre (HSCIC). Breast Screening Programme, England—2013–14 [online], (2015).
Netherlands Centre for Population Screening, Breast Cancer Screening Programme. Breast Cancer Screening Factsheet [online], (2015).
Lovrics, P. J. et al. The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer. Am. J. Surg. 197, 740–746 (2009).
Mittmann, N. et al. Health system costs for stage-specific breast cancer: a population-based approach. Curr. Oncol. 21, 281–293 (2014).
[No authors listed] Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. N. Engl. J. Med. 333, 1444–1455 (1995).
Morris, A. D. et al. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J. Sci. Am. 3, 6–12 (1997).
Dodd, G. D., Fry, K., Delany, W. in Management of the patient with cancer (ed. Nealon, T. F. Jr) 88–113 (Saunders, 1965).
Frank, H. A., Hall, F. M. & Steer, M. L. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. N. Engl. J. Med. 295, 259–260 (1976).
Rusnak, C. H., Pengelly, D. B., Hosie, R. T. & Rusnak, C. N. Preoperative needle localization to detect early breast cancer. Am. J. Surg. 157, 505–507 (1989).
Ahmed, M. & Douek, M. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res. Treat. 140, 435–446 (2013).
Dua, S. M., Gray, R. J. & Keshtgar, M. Strategies for localisation of impalpable breast lesions. Breast 20, 246–253 (2011).
Homer, M. J. Transection of the localization hooked wire during breast biopsy. AJR Am. J. Roentgenol. 141, 929–930 (1983).
Davis, P. S., Wechsler, R. J., Feig, S. A. & March, D. E. Migration of breast biopsy localization wire. AJR Am. J. Roentgenol. 150, 787–788 (1988).
Grassi, R. et al. Unusual migration in abdomen of a wire for surgical localization of breast lesions. Acta Radiol. 45, 254–258 (2004).
Medina-Franco, H. et al. Radioguided occult lesion localization (ROLL) versus wire-guided lumpectomy for non-palpable breast lesions: a randomized prospective evaluation. J. Surg. Oncol. 97, 108–111 (2008).
Ocal, K. et al. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (Sao Paulo) 66, 1003–1007 (2011).
Mariscal Martínez, A. et al. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. AJR Am. J. Roentgenol. 193, 1001–1009 (2009).
Postma, E. L. et al. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res. Treat. 136, 469–478 (2012).
Jeevan, R. et al. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ 345, e4505 (2012).
McGhan, L. J. et al. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann. Surg. Oncol. 18, 3096–3101 (2011).
Postma, E. L. et al. Cost-effectiveness of radioguided occult lesion localization (ROLL) versus wire-guided localization (WGL) in breast conserving surgery for nonpalpable breast cancer: results from a randomized controlled multicenter trial. Ann. Surg. Oncol. 20, 2219–2226 (2013).
Rao, R. et al. Experience with seed localization for nonpalpable breast lesions in a public health care system. Ann. Surg. Oncol. 17, 3241–3246 (2010).
Nasrinossadat, A. et al. Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areas. Asian Pac. J. Cancer Prev. 12, 1189–1192 (2011).
Hrung, J. M., Sonnad, S. S., Schwartz, J. S. & Langlotz, C. P. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad. Radiol. 6, 387–397 (1999).
Peters, N. H. et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246, 116–124 (2008).
Siegmann-Luz, K. C., Bahrs, S. D., Preibsch, H., Hattermann, V. & Claussen, C. D. Management of breast lesions detectable only on MRI. Rofo 186, 30–36 (2014).
Gossmann, A. et al. Real-time MR-guided wire localization of breast lesions by using an open 1.0-T imager: initial experience. Radiology 247, 535–542 (2008).
Landheer, M. L. et al. MRI-guided preoperative wire localization of nonpalpable breast lesions. Clin. Imaging 30, 229–233 (2006).
van den Bosch, M. A. et al. MRI-guided needle localization of suspicious breast lesions: results of a freehand technique. Eur. Radiol. 16, 1811–1817 (2006).
Luini, A. et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br. J. Surg. 86, 522–525 (1999).
Monti, S. et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann. Surg. Oncol. 14, 2928–2931 (2007).
Chow, M. P. et al. Isotope-guided surgery for nonpalpable breast cancer. World J. Surg. 35, 165–169 (2011).
Kim, J., Chung, D. & Spillane, A. Combined radioguided occult lesion and sentinel node localization for breast cancer. ANZ J. Surg. 74, 550–553 (2004).
van Rijk, M. C. et al. Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer. Ann. Surg. Oncol. 14, 627–632 (2007).
Zgajnar, J. et al. Radioguided excision of the nonpalpable breast cancer and simultaneous sentinel lymphnode biopsy using a single radiopharmaceutical: an original approach to accurate administration of the blue dye. J. Surg. Oncol. 83, 48–50 (2003).
Gray, R. J., Pockaj, B. A., Karstaedt, P. J. & Roarke, M. C. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am. J. Surg. 188, 377–380 (2004).
Gray, R. J. et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann. Surg. Oncol. 8, 711–715 (2001).
Hughes, J. H. et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 14, 153–157 (2008).
Lovrics, P. J. et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann. Surg. Oncol. 18, 3407–3414 (2011).
Donker, M. et al. Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique. Ann. Surg. Oncol. 20, 2569–2575 (2013).
Gobardhan, P. D. et al. The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy. Ann. Oncol. 24, 668–673 (2013).
Ahmed, M. & Douek, M. Radioactive seed localisation (RSL) in the treatment of non-palpable breast cancers: Systematic review and meta-analysis. Breast 22, 383–388 (2013).
Barentsz, M. W. et al. Radioactive seed localization for non-palpable breast cancer. Br. J. Surg. 100, 582–588 (2013).
Moreno, M. et al. Radioguided breast surgery for occult lesion localization—correlation between two methods. J. Exp. Clin. Cancer Res. 27, 29 (2008).
Rampaul, R. S. et al. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br. J. Surg. 91, 1575–1577 (2004).
Ahmed, M., van Hemelrijck, M. & Douek, M. Systematic review of radioguided versus wire-guided localization in the treatment of non-palpable breast cancers. Breast Cancer Res. Treat. 140, 241–252 (2013).
Cochrane, R. A., Valasiadou, P., Wilson, A. R., Al-Ghazal, S. K. & Macmillan, R. D. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br. J. Surg. 90, 1505–1509 (2003).
Ahmed, M. Significance of the volume of excised specimens in radio guided occult lesion localization (ROLL). J. Surg. Oncol. 107, 874 (2013).
Veronesi, U. et al. Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. Oncologist 15, 1248–1252 (2010).
Burak, W. E. Jr et al. Biodistribution and localization of radiolabeled NR-LU-10 Fab fragment in human breast cancer xenografts. Nucl. Med. Biol. 25, 633–637 (1998).
Burak, W. E. Jr et al. Radioimmunoguided breast surgery using radiolabeled antibody NR-LU-10 Fab: a pilot study. Tumori 87, 142–146 (2001).
Percivale, P. et al. Radioimmunoguided surgery after primary treatment of locally advanced breast cancer. J. Clin. Oncol. 14, 1599–1603 (1996).
Hall, N. C., Povoski, S. P., Murrey, D. A., Knopp, M. V. & Martin, E. W. Jr. Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer. World J. Surg. Oncol. 5, 143 (2007).
Anninga, B., Ahmed, M. & Douek, M. Magnetic guidance for cancer surgery. Br. J. Surg. 102, e12–e14 (2015).
Ahmed, M., de Rosales, R. T. & Douek, M. Preclinical studies of the role of iron oxide magnetic nanoparticles for nonpalpable lesion localization in breast cancer. J. Surg. Res. 185, 27–35 (2013).
Anninga, B. et al. Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model. Breast Cancer Res. Treat. 141, 33–42 (2013).
Ahmed, M. et al. Magnetic sentinel node and occult lesion localization in breast cancer (MagSNOLL Trial). Br. J. Surg. 102, 646–652 (2015).
UK Clinical Research Network: Portfolio Database. Magnetic Sentinel Node and Occult Lesion Localisation (MagSNOLL) [online], (2015).
Czarnecki, D. J., Feider, H. K. & Splittgerber, G. F. Toluidine blue dye as a breast localization marker. AJR Am. J. Roentgenol. 153, 261–263 (1989).
Gumus, M. et al. How long will I be blue? Prolonged skin staining following sentinel lymph node biopsy using intradermal patent blue dye. Breast Care (Basel) 8, 199–202 (2013).
Ahmed, M., Purushotham, A. D., Horgan, K., Klaase, J. M. & Douek, M. Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer. Br. J. Surg. 102, 169–181 (2015).
Tummers, Q. R. et al. Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and methylene blue. Eur. J. Surg. Oncol. 40, 850–858 (2014).
Tang, J. et al. Radiocolloid in combination with methylene dye localization, rather than wire localization, is a preferred procedure for excisional biopsy of nonpalpable breast lesions. Ann. Surg. Oncol. 18, 109–113 (2011).
Mullen, D. J., Eisen, R. N., Newman, R. D., Perrone, P. M. & Wilsey, J. C. The use of carbon marking after stereotactic large-core-needle breast biopsy. Radiology 218, 255–260 (2001).
Canavese, G. et al. Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. Eur. J. Surg. Oncol. 21, 47–49 (1995).
Ko, K. et al. The value of ultrasound-guided tattooing localization of nonpalpable breast lesions. Korean J. Radiol. 8, 295–301 (2007).
Ruiz-Delgado, M. L., López-Ruiz, J. A. & Sáiz-López, A. Abnormal mammography and sonography associated with foreign-body giant-cell reaction after stereotactic vacuum-assisted breast biopsy with carbon marking. Acta Radiol. 49, 1112–1118 (2008).
Wild, J. J. & Neal, D. Use of high-frequency ultrasonic waves for detecting changes of texture in living tissues. Lancet 1, 655–657 (1951).
Cole-Beuglet, C. et al. Ultrasound mammography: a comparison with radiographic mammography. Radiology 139, 693–698 (1981).
Jellins, J., Kossoff, G., Buddee, F. W. & Reeve, T. S. Ultrasonic visualization of the breast. Med. J. Aust. 1, 305–307 (1971).
Kobayashi, T. Diagnostic ultrasound in breast cancer: analysis of retrotumorous echo patterns correlated with sonic attenuation by cancerous connective tissue. J. Clin. Ultrasound 7, 471–479 (1979).
Ahmed, M. & Douek, M. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res. Treat. 140, 435–446 (2013).
Parker, S. H. et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 193, 359–364 (1994).
Ahmed, M., Abdullah, N., Cawthorn, S., Usiskin, S. I. & Douek, M. Why should breast surgeons use ultrasound? Breast Cancer Res. Treat. 145, 1–4 (2014).
Krekel, N. M. et al. Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial. Lancet Oncol. 14, 48–54 (2013).
Smith, L. F., Henry-Tillman, R., Rubio, I. T., Korourian, S. & Klimberg, V. S. Intraoperative localization after stereotactic breast biopsy without a needle. Am. J. Surg. 182, 584–589 (2001).
Rubio, I. T., Henry-Tillman, R. & Klimberg, V. S. Surgical use of breast ultrasound. Surg. Clin. North Am. 83, 771–788 (2003).
James, T. A. et al. Intraoperative ultrasound versus mammographic needle localization for ductal carcinoma in situ. Ann. Surg. Oncol. 16, 1164–1169 (2009).
Rubio, I. T., Esgueva, A. & Salvador, R. Intraoperative ultrasound guided lumpectomy versus mammographically needle localization for breast cancer patients after neoadjuvant treatment [abstract 1251]. Eur. J. Cancer 49, S260 (2013).
Ramos, M. et al. Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer. Breast 22, 520–524 (2012).
Krekel, N. M. et al. A comparison of three methods for nonpalpable breast cancer excision. Eur. J. Surg. Oncol. 37, 109–115 (2011).
Rahusen, F. D. et al. Ultrasound-guided lumpectomy of nonpalpable breast cancers: a feasibility study looking at the accuracy of obtained margins. J. Surg. Oncol. 72, 72–76 (1999).
Krekel, N. M. et al. Optimising surgical accuracy in palpable breast cancer with intra-operative breast ultrasound—feasibility and surgeons' learning curve. Eur. J. Surg. Oncol. 37, 1044–1050 (2011).
Arentz, C. et al. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann. Surg. Oncol. 17 (Suppl. 3), 378–383 (2010).
Larrieux, G., Cupp, J. A., Liao, J., Scott-Conner, C. E. & Weigel, R. J. Effect of introducing hematoma ultrasound-guided lumpectomy in a surgical practice. J. Am. Coll. Surg. 215, 237–243 (2012).
Tafra, L. et al. Pilot trial of cryoprobe-assisted breast-conserving surgery for small ultrasound-visible cancers. Ann. Surg. Oncol. 10, 1018–1024 (2003).
Tafra, L. et al. Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumors. Am. J. Surg. 192, 462–470 (2006).
Salmon, R. J., Mirlesse, V., Le Gal, M. & Durand, J. C. The value of preoperative location of microcalcifications without palpable breast tumors [French]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 19, 333–336 (1990).
Giess, C. S., Raza, S. & Birdwell, R. L. Distinguishing breast skin lesions from superficial breast parenchymal lesions: diagnostic criteria, imaging characteristics, and pitfalls. Radiographics 31, 1959–1972 (2011).
Homer, M. J. Proper placement of a metallic marker on an area of concern in the breast. AJR Am. J. Roentgenol. 167, 390–391 (1996).
Klimberg, V. S. et al. Long-term results of phase II ablation after breast lumpectomy added to extend intraoperative margins (ABLATE l) trial. J. Am. Coll. Surg. 218, 741–749 (2014).
Mackey, A. et al. Radiofrequency ablation after breast lumpectomy added to extend intraoperative margins in the treatment of breast cancer (ABLATE): a single-institution experience. Ann. Surg. Oncol. 19, 2618–2619 (2012).
Rubio, I. T., Landolfi, S., Molla, M., Cortes, J. & Xercavins, J. Breast-conservative surgery followed by radiofrequency ablation of margins decreases the need for a second surgical procedure for close or positive margins. Clin. Breast Cancer 14, 346–351 (2014).
Wilson, M. et al. Long-term results of excision followed by radiofrequency ablation as the sole means of local therapy for breast cancer. Ann. Surg. Oncol. 19, 3192–3198 (2012).
Noguchi, M., Motoyoshi, A., Earashi, M. & Fujii, H. Long-term outcome of breast cancer patients treated with radiofrequency ablation. Eur. J. Surg. Oncol. 38, 1036–1042 (2012).
Palussiere, J. et al. Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes. Radiology 264, 597–605 (2012).
Vilar, V. S. et al. Analysis by MRI of residual tumor after radiofrequency ablation for early stage breast cancer. AJR Am. J. Roentgenol. 198, W285–W291 (2012).
Kinoshita, T., Iwamoto, E., Tsuda, H. & Seki, K. Radiofrequency ablation as local therapy for early breast carcinomas. Breast Cancer 18, 10–17 (2011).
van Esser, S. et al. Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study. Ann. Surg. Oncol. 16, 2259–2263 (2009).
Zhou, W. et al. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology 263, 364–373 (2012).
Littrup, P. J. et al. Cryotherapy for breast cancer: a feasibility study without excision. J. Vasc. Interv. Radiol. 20, 1329–1341 (2009).
Medina-Franco, H. et al. Radiofrequency ablation of invasive breast carcinomas: a phase II trial. Ann. Surg. Oncol. 15, 1689–1695 (2008).
Morin, J. et al. Magnetic resonance-guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results. Can. J. Surg. 47, 347–351 (2004).
Motoyoshi, A., Noguchi, M., Earashi, M., Zen, Y. & Fujii, H. Histopathological and immunohistochemical evaluations of breast cancer treated with radiofrequency ablation. J. Surg. Oncol. 102, 385–391 (2010).
Mumtaz, H. et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology 200, 651–658 (1996).
Nagashima, T. et al. Surrounding rim formation and reduction in size after radiofrequency ablation for primary breast cancer. Jpn J. Radiol. 27, 197–204 (2009).
Noguchi, M. et al. Radiofrequency ablation of small breast cancer followed by surgical resection. J. Surg. Oncol. 93, 120–128 (2006).
Ohtani, S. et al. Radiofrequency ablation of early breast cancer followed by delayed surgical resection—a promising alternative to breast-conserving surgery. Breast 20, 431–436 (2011).
Oura, S. et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 14, 48–54 (2007).
Pfleiderer, S. O. et al. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur. Radiol. 12, 3009–3014 (2002).
Pusztaszeri, M., Vlastos, G., Kinkel, K. & Pelte, M. F. Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation. Cryobiology 55, 44–51 (2007).
Sabel, M. S. et al. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann. Surg. Oncol. 11, 542–549 (2004).
Singletary, E. S. Feasibility of radiofrequency ablation for primary breast cancer. Breast Cancer 10, 4–9 (2003).
Tsuda, H. Radiofrequency ablation therapy for primary breast cancer: expectations and problems as a novel breast conservation therapy. Breast Cancer 18, 1–2 (2011).
Vargas, H. I. et al. Focused microwave phased array thermotherapy for ablation of early-stage breast cancer: results of thermal dose escalation. Ann. Surg. Oncol. 11, 139–146 (2004).
Wiksell, H. et al. Feasibility study on the treatment of small breast carcinoma using percutaneous US-guided preferential radiofrequency ablation (PRFA). Breast 19, 219–225 (2010).
Yamamoto, N. et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. Breast Cancer 18, 3–9 (2011).
Yamamoto, S., Maeda, N., Yoshimura, K. & Oka, M. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography–lymphography. Breast 22, 933–937 (2013).
Yoshinaga, Y. et al. Image and pathological changes after radiofrequency ablation of invasive breast cancer: a pilot study of nonsurgical therapy of early breast cancer. World J. Surg. 37, 356–363 (2013).
Zhou, W. et al. Image and pathological changes after microwave ablation of breast cancer: a pilot study. Eur. J. Radiol. 83, 1771–1777 (2014).
Akimov, A. B. et al. Nd:YAG interstitial laser thermotherapy in the treatment of breast cancer. Lasers Surg. Med. 22, 257–267 (1998).
Bloom, K. J., Dowlat, K. & Assad, L. Pathologic changes after interstitial laser therapy of infiltrating breast carcinoma. Am. J. Surg. 182, 384–388 (2001).
Burak, W. E. Jr et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 98, 1369–1376 (2003).
Dooley, W. C., Vargas, H. I., Fenn, A. J., Tomaselli, M. B. & Harness, J. K. Focused microwave thermotherapy for preoperative treatment of invasive breast cancer: a review of clinical studies. Ann. Surg. Oncol. 17, 1076–1093 (2010).
Dowlatshahi, K., Francescatti, D. S. & Bloom, K. J. Laser therapy for small breast cancers. Am. J. Surg. 184, 359–363 (2002).
Earashi, M., Noguchi, M., Motoyoshi, A. & Fujii, H. Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer 14, 39–47 (2007).
Fornage, B. D. et al. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231, 215–224 (2004).
Garbay, J. R. et al. Radiofrequency thermal ablation of breast cancer local recurrence: a phase II clinical trial. Ann. Surg. Oncol. 15, 3222–3226 (2008).
Gardner, R. A. et al. Focused microwave phased array thermotherapy for primary breast cancer. Ann. Surg. Oncol. 9, 326–332 (2002).
Haraldsdottir, K. H. et al. Interstitial laser thermotherapy (ILT) of breast cancer. Eur. J. Surg. Oncol. 34, 739–745 (2008).
Harries, S. A. et al. Interstitial laser photocoagulation as a treatment for breast cancer. Br. J. Surg. 81, 1617–1619 (1994).
Hayashi, A. H. et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am. J. Surg. 185, 429–435 (2003).
Hung, W. K., Mak, K. L., Ying, M. & Chan, M. Radiofrequency ablation of breast cancer: a comparative study of two needle designs. Breast Cancer 18, 124–128 (2011).
Khatri, V. P. et al. A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinomas: use of saline-cooled tip electrode. Ann. Surg. Oncol. 14, 1644–1652 (2007).
Manenti, G. et al. Small breast cancers: in vivo percutaneous US-guided radiofrequency ablation with dedicated cool-tip radiofrequency system. Radiology 251, 339–346 (2009).
Manenti, G. et al. Percutaneous local ablation of unifocal subclinical breast cancer: clinical experience and preliminary results of cryotherapy. Eur. Radiol. 21, 2344–2353 (2011).
Manenti, G. et al. Subclinical breast cancer: minimally invasive approaches. Our experience with percutaneous radiofrequency ablation vs. cryotherapy. Breast Care (Basel) 8, 356–360 (2013).
Pfleiderer, S. O., Marx, C., Camara, O., Gajda, M. & Kaiser, W. A. Ultrasound-guided, percutaneous cryotherapy of small (< or = 15 mm) breast cancers. Invest. Radiol. 40, 472–477 (2005).
Schassburger, K. U. et al. Minimally-invasive treatment of early stage breast cancer: a feasibility study using radiofrequency ablation under local anesthesia. Breast 23, 152–158 (2014).
Waaijer, L. et al. Radiofrequency ablation of small breast tumours: evaluation of a novel bipolar cool-tip application. Eur. J. Surg. Oncol. 40, 1222–1229 (2014).
Wu, F. et al. A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br. J. Cancer 89, 2227–2233 (2003).
Schmitz, A. C., Gianfelice, D., Daniel, B. L., Mali, W. P. & van den Bosch, M. A. Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions. Eur. Radiol. 18, 1431–1441 (2008).
Peek, M. C. et al. A systematic review of high-intensity focused ultrasound (HIFU) in the treatment of breast tumours. Br. J. Surg. 102, 873–882 (2015).
Kim, S. H. et al. The potential role of dynamic MRI in assessing the effectiveness of high-intensity focused ultrasound ablation of breast cancer. Int. J. Hyperthermia 26, 594–603 (2010).
Wu, F. et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res. Treat. 92, 51–60 (2005).
van Riet, Y. E. et al. Localization of non-palpable breast cancer using a radiolabelled titanium seed. Br. J. Surg. 97, 1240–1245 (2010).
Barentsz, M. W. et al. Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature. Breast Cancer Res. Treat. 135, 209–219 (2012).
Krekel, N. M. et al. A comparison of three methods for nonpalpable breast cancer excision. Eur. J. Surg. Oncol. 37, 109–115 (2011).
Haid, A. et al. Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer. Ann. Surg. Oncol. 14, 3090–3101 (2007).
Bennett, I. C., Greenslade J. & Chiam, H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J. Surg. 29, 369–374 (2005).
Rahusen, F. D. et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann. Surg. Oncol. 9, 994–998 (2002).
Paramo, J. C., Landeros, M., McPhee, M. D. & Mesko, T. W. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. Breast J. 5, 389–394 (1999).
Snider, H. C. Jr & Morrison, D. G. Intraoperative ultrasound localization of nonpalpable breast lesions. Ann. Surg. Oncol. 6, 308–314 (1999).
Author information
Authors and Affiliations
Contributions
All authors researched the data for the article, provided substantial contributions to discussions of its content, wrote the article and undertook review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
M.A. and M.D. receive research grants from Theraclion Ltd (Malakoff, France) for the HIFU-F trial and have received equipment support for the MagSNOLL trial from Endomagnetics Ltd. All of these trials have been academically run and sponsored by King's College London. The other authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ahmed, M., Rubio, I., Klaase, J. et al. Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat Rev Clin Oncol 12, 645–663 (2015). https://doi.org/10.1038/nrclinonc.2015.161
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2015.161
This article is cited by
-
Impact of Revised Margin Negative Guidelines in Breast Cancer on Survival: Single Institution Audit
Indian Journal of Surgery (2023)
-
Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance
Breast Cancer Research (2021)
-
Nanoparticle Formulation of Indocyanine Green Improves Image-Guided Surgery in a Murine Model of Breast Cancer
Molecular Imaging and Biology (2020)